Equifax CapEx decreased by 7.4% to $120.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.3%, from $107.20M to $120.40M. Over 4 years (FY 2021 to FY 2025), CapEx shows relatively stable performance with a 0.7% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $122.50M | $97.40M | $136.10M | $156.50M | $158.90M | $153.00M | $156.10M | $158.30M | $163.00M | $134.30M | $145.70M | $131.90M | $136.70M | $124.00M | $118.90M | $107.20M | $122.20M | $122.00M | $130.00M | $120.40M |
| QoQ Change | — | -20.5% | +39.7% | +15.0% | +1.5% | -3.7% | +2.0% | +1.4% | +3.0% | -17.6% | +8.5% | -9.5% | +3.6% | -9.3% | -4.1% | -9.8% | +14.0% | -0.2% | +6.6% | -7.4% |
| YoY Change | — | — | — | — | +29.7% | +57.1% | +14.7% | +1.2% | +2.6% | -12.2% | -6.7% | -16.7% | -16.1% | -7.7% | -18.4% | -18.7% | -10.6% | -1.6% | +9.3% | +12.3% |